For the ECG pattern shown, management should be urgent clinician-led, not self-medication.
1. If unstable: immediate synchronized DC cardioversion
Treat as unstable if there is hypotension, ischemic chest pain, pulmonary edema/severe breathlessness, altered consciousness, or shock.
- Synchronized electrical cardioversion is the treatment of choice.
- Anticoagulation should not delay cardioversion when there is hemodynamic instability. - Fuster and Hurst's The Heart, p. 1178
2. If stable: rate control plus stroke prevention assessment
Rate control options, selected according to blood pressure, heart failure status, ejection fraction, asthma/COPD, renal function, and concurrent medicines:
- A beta-blocker, such as metoprolol
- Diltiazem or verapamil if LVEF is >40% and there is no decompensated heart failure
- Digoxin may be considered, particularly in heart failure or sedentary patients
Flutter can be harder to rate-control than atrial fibrillation. - Harrison’s Principles of Internal Medicine, 22nd ed., p. 1988
3. Anticoagulation
Assess embolic risk using CHA₂DS₂-VASc and bleeding risk. Atrial flutter is managed for anticoagulation similarly to atrial fibrillation.
- If flutter duration is >48 hours or unknown and cardioversion is planned: anticoagulation and a TEE-guided or delayed-cardioversion strategy are generally needed.
- After cardioversion, anticoagulation is commonly continued for at least 4 weeks, with longer-term treatment determined by stroke-risk factors and future AF/flutter risk.
- A DOAC is commonly used when appropriate; warfarin is used in some situations, such as mechanical valves or moderate-to-severe rheumatic mitral stenosis.
The
2024 ESC guidance summary lists beta-blockers, digoxin, and diltiazem/verapamil in appropriate patients for rate control, alongside anticoagulation assessment.
4. Restore sinus rhythm
For symptomatic, persistent, or difficult-to-control flutter:
- Electrical cardioversion is highly effective.
- Pharmacologic conversion can use agents such as ibutilide in a monitored setting. Other antiarrhythmics are individualized by cardiology because of proarrhythmia and structural-heart-disease considerations.
5. Definitive treatment
For typical CTI-dependent atrial flutter, catheter ablation is usually preferred first-line definitive therapy. It has high long-term success, commonly over 90-95%, with low recurrence of typical flutter. - Harrison’s Principles of Internal Medicine, 22nd ed., p. 1988; The Washington Manual of Medical Therapeutics, p. 237
Also investigate and treat triggers
Check electrolytes, thyroid function, anemia/infection, alcohol or stimulant use, ischemia, sleep apnea, lung disease, and obtain echocardiography where indicated.
For this ECG: arrange same-day medical/cardiology review. Go to emergency care immediately if there is chest pain, breathlessness, fainting, confusion, low blood pressure, or worsening palpitations.